These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The application advances of bisphosphonates in bone metastasis]. Liang P Zhongguo Gu Shang; 2008 Jun; 21(6):480-2. PubMed ID: 19108448 [TBL] [Abstract][Full Text] [Related]
4. The antitumor potential of bisphosphonates. Clézardin P Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis. Clézardin P; Gligorov J; Delmas P Joint Bone Spine; 2000 Jan; 67(1):22-9. PubMed ID: 10773965 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates for breast cancer. Pavlakis N; Stockler M Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664 [TBL] [Abstract][Full Text] [Related]
7. Rationale for the use of bisphosphonates in bone metastases. Kanis JA; McCloskey EV; Taube T; O'Rourke N Bone; 1991; 12 Suppl 1():S13-8. PubMed ID: 1954047 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of bisphosphonates. Green JR Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates in cancer therapy. Green JR Curr Opin Oncol; 2002 Nov; 14(6):609-15. PubMed ID: 12409650 [TBL] [Abstract][Full Text] [Related]
10. Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment. Mundy GR; Yoneda T; Hiraga T Semin Oncol; 2001 Apr; 28(2 Suppl 6):35-44. PubMed ID: 11346863 [TBL] [Abstract][Full Text] [Related]
11. The role of bisphosphonates in breast cancer. Theriault RL J Natl Compr Canc Netw; 2003 Apr; 1(2):232-41. PubMed ID: 19768882 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates and bone metastases: current status and future directions. Krempien R; Niethammer A; Harms W; Debus J Expert Rev Anticancer Ther; 2005 Apr; 5(2):295-305. PubMed ID: 15877526 [TBL] [Abstract][Full Text] [Related]
13. New bisphosphonates in the treatment of bone metastases. Averbuch SD Cancer; 1993 Dec; 72(11 Suppl):3443-52. PubMed ID: 8242577 [TBL] [Abstract][Full Text] [Related]
14. The role of bisphosphonates in the treatment of bone metastases--the U.S. experience. Harvey HA; Lipton A Support Care Cancer; 1996 May; 4(3):213-7. PubMed ID: 8739655 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis. Green JR; Clézardin P Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S3-9. PubMed ID: 12562045 [TBL] [Abstract][Full Text] [Related]
17. The use of bisphosphonates in patients with breast cancer. Van Poznak CH Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566 [TBL] [Abstract][Full Text] [Related]
18. Use of bisphosphonates in patients with metastatic bone disease. Berenson JR; Lipton A Oncology (Williston Park); 1998 Nov; 12(11):1573-9; discussion 1579-81. PubMed ID: 9834935 [TBL] [Abstract][Full Text] [Related]
19. The potential role of bisphosphonates in prostate cancer. Oades GM; Coxon J; Colston KW Prostate Cancer Prostatic Dis; 2002; 5(4):264-72. PubMed ID: 12627210 [TBL] [Abstract][Full Text] [Related]